Home > National Drug Code (NDC) > Triple Antibiotic

Triple Antibiotic - 0168-0012-31 - (Neomycin and Polymyxin B Sulfates and Bacitracin Zinc)

Alphabetical Index


Drug Information of Triple Antibiotic

Product NDC: 0168-0012
Proprietary Name: Triple Antibiotic
Non Proprietary Name: Neomycin and Polymyxin B Sulfates and Bacitracin Zinc
Active Ingredient(s): 400; 3.5; 5000    [USP'U]/g; mg/g; [USP'U]/g & nbsp;   Neomycin and Polymyxin B Sulfates and Bacitracin Zinc
Administration Route(s): TOPICAL
Dosage Form(s): OINTMENT
Coding System: National Drug Codes(NDC)

Labeler Information of Triple Antibiotic

Product NDC: 0168-0012
Labeler Name: E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.
Product Type: HUMAN OTC DRUG
FDA Application Number: part333B
Marketing Category: OTC MONOGRAPH FINAL
Start Marketing Date: 20100106

Package Information of Triple Antibiotic

Package NDC: 0168-0012-31
Package Description: 1 TUBE in 1 CARTON (0168-0012-31) > 28.35 g in 1 TUBE

NDC Information of Triple Antibiotic

NDC Code 0168-0012-31
Proprietary Name Triple Antibiotic
Package Description 1 TUBE in 1 CARTON (0168-0012-31) > 28.35 g in 1 TUBE
Product NDC 0168-0012
Product Type Name HUMAN OTC DRUG
Non Proprietary Name Neomycin and Polymyxin B Sulfates and Bacitracin Zinc
Dosage Form Name OINTMENT
Route Name TOPICAL
Start Marketing Date 20100106
Marketing Category Name OTC MONOGRAPH FINAL
Labeler Name E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.
Substance Name BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
Strength Number 400; 3.5; 5000
Strength Unit [USP'U]/g; mg/g; [USP'U]/g
Pharmaceutical Classes

Complete Information of Triple Antibiotic


General Information